Prospective Study Demonstrates EndoPredict® Can Guide Chemotherapy Decision For Women with Early-Stage Breast Cancer

World News: . []

SALT LAKE CITY Dec 07 2018 GLOBE NEWSWIRE -- Myriad Genetics, Inc NASDAQ MYGN a global leader in personalized medicine today announced that academic researchers from the Technical University of Munich TUM presented the first prospecti ve outc...

More news and information about Myriad Genetics, Inc.

Published By:

Globe Newswire: 13:32 GMT Friday 7th December 2018

Published: .

Search for other references to "prospective" on SPi News


Previous StoryNext Story

SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2019. [Admin Only]
Sector Publishing Intelligence Ltd.
Agriculture House, Acland Road, DORCHESTER, Dorset DT1 1EF United Kingdom
Registered in England and Wales number 07519380.
Privacy Policy | Terms and Conditions | Contact Us